查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1702264

失眠市場規模、佔有率、趨勢及預測（按治療類型、藥物類別、配銷通路和地區），2025 年至 2033 年

Insomnia Market Size, Share, Trends and Forecast by Therapy Type, Drug Class, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球失眠市場規模價值 53.4 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 67.8 億美元，2025-2033 年期間的複合年成長率為 2.55%。北美目前佔據市場主導地位，到 2024 年將佔據超過 36.4% 的顯著市場。現代生活方式和壓力導致的盛行率不斷上升、診斷技術的進步提高了準確性、對新療法的深入研究、醫療保健支出的增加、數位健康解決方案的整合、策略性產業合作以及消費者對非藥物治療的偏好日益成長是推動市場成長的一些因素。除此之外，先進的醫療保健、高睡眠障礙盛行率以及創新治療方法的採用進一步增加了失眠市場的佔有率。

失眠是一種睡眠障礙，它會降低能量水平並影響個人的情緒、健康、工作表現和整體生活品質。其常見原因包括壓力、長途旅行、繁忙的工作日程、不良的睡眠習慣、暴飲暴食以及過量攝取尼古丁、咖啡因和酒精。它也可能與精神健康障礙有關，例如創傷後壓力症候群，以及使用抗憂鬱藥物治療氣喘或血壓以及使用非處方藥 (OTC) 來緩解疼痛、過敏和感冒。其治療方案目前在全球範圍內均有提供，例如認知行為療法 (CBT)、非處方助眠劑以及處方藥如 Eszopiclone 和 Ramelteon。

失眠市場趨勢：

冠狀病毒病（COVID-19）大流行為人們的生活帶來了前所未有的變化，包括社會隔離以及無數的工作挑戰和家庭義務。這是一個重大的壓力事件，影響了數百萬人的睡眠模式並促進了市場的成長。此外，慢性疼痛、癌症、糖尿病、心臟病、氣喘、胃食道逆流 (GERD)、甲狀腺功能亢進、帕金森氏症和阿茲海默症等疾病通常與失眠有關。因此，患有這些疾病的人數不斷增加，推動了對失眠藥物的需求。除此之外，月經週期和更年期期間的荷爾蒙變化可能會導致失眠的風險，這也促進了市場的成長。此外，由於睡眠模式、活動和健康狀況的改變以及處方藥使用量的增加會增加老年人失眠的可能性，全球老年人口的成長正在催化對失眠醫療的需求。此外，預計對預防、檢測、治療和管理失眠的新療法、干預措施和測試的投資增加將推動市場發展。

本報告回答的關鍵問題

  • 失眠市場到底有多大？失眠市場未來前景如何？
  • 推動失眠市場發展的關鍵因素有哪些？
  • 哪個地區佔失眠市場佔有率最大？
  • 全球失眠市場領先的公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球失眠市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依治療類型

  • 非藥物治療
    • 關鍵部分
      • 催眠療法
      • 認知行為療法
      • 醫療器材
      • 其他
  • 藥物治療
    • 關鍵部分
      • 處方助眠劑
      • 非處方助眠藥

第7章：市場區隔：依藥品類別

  • 抗憂鬱藥
  • 褪黑激素拮抗劑
  • 苯二氮平類藥物
  • 非苯二氮平類藥物
  • 食慾素拮抗劑
  • 其他

第8章：市場區隔：按配銷通路

  • 醫院藥房
  • 零售藥局
  • 藥局
  • 網路藥局

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Astellas Pharma Inc.
    • Aurobindo Pharma Limited
    • Biocodex
    • Eisai Co. Ltd.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co. Inc.
    • Neurim Pharmaceuticals Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
    • Takeda Pharmaceutical Company Limited
    • Vanda Pharmaceuticals Inc.
Product Code: SR112025A6148

The global insomnia market size was valued at USD 5.34 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.78 Billion by 2033, exhibiting a CAGR of 2.55% during 2025-2033. North America currently dominates the market, holding a significant market share of over 36.4% in 2024. Increasing prevalence due to modern lifestyles and stress, advancements in diagnostic technologies enhancing accuracy, robust research into novel therapies, rising healthcare expenditures, integration of digital health solutions, strategic industry collaborations, and growing consumer preference for non-pharmacological treatments are some of the factors bolstering the market growth. In addition to this, advanced healthcare, high sleep disorder prevalence, and adoption of innovative treatments are further increasing the insomnia market share.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

Breakup by Therapy Type:

  • Non-Pharmacological Therapy
  • Hypnotherapy
  • Cognitive Behavioral Therapy
  • Medical Devices
  • Others
  • Pharmacological Therapy
  • Prescription Sleep Aids
  • Over-The-Counter Sleep Aids

Breakup by Drug Class:

  • Antidepressants
  • Melatonin Antagonist
  • Benzodiazepines
  • Nonbenzodiazepines
  • Orexin Antagonist
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1.How big is the insomnia market?
  • 2.What is the future outlook of insomnia market?
  • 3.What are the key factors driving the insomnia market?
  • 4.Which region accounts for the largest insomnia market share?
  • 5.Which are the leading companies in the global insomnia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Insomnia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapy Type

  • 6.1 Non-Pharmacological Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Hypnotherapy
      • 6.1.2.2 Cognitive Behavioral Therapy
      • 6.1.2.3 Medical Devices
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Pharmacological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Prescription Sleep Aids
      • 6.2.2.2 Over-The-Counter Sleep Aids
    • 6.2.3 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Antidepressants
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Melatonin Antagonist
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Benzodiazepines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Nonbenzodiazepines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Orexin Antagonist
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Pharmacies
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aurobindo Pharma Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Biocodex
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eisai Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Mallinckrodt Pharmaceuticals
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Neurim Pharmaceuticals Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vanda Pharmaceuticals Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Insomnia Market: Major Drivers and Challenges
  • Figure 2: Global: Insomnia Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2024
  • Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2024
  • Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Insomnia Industry: SWOT Analysis
  • Figure 82: Global: Insomnia Industry: Value Chain Analysis
  • Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Insomnia Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
  • Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Insomnia Market: Competitive Structure
  • Table 7: Global: Insomnia Market: Key Players